129 related articles for article (PubMed ID: 3119370)
1. Continuous gonadotropin-releasing hormone for ovulation induction in polycystic ovarian disease.
Stuckey BG; Keogh EJ; Pullan PT; Beilby JA; Thompson RI; Evans DV
Fertil Steril; 1987 Dec; 48(6):1055-7. PubMed ID: 3119370
[No Abstract] [Full Text] [Related]
2. Induction of ovulation with various regimens of luteinizing hormone-releasing hormone administration.
Gual C
Basic Life Sci; 1974; 4(PART A):355-70. PubMed ID: 4614788
[No Abstract] [Full Text] [Related]
3. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation.
Venturini PL; Remorgida V; Anserini P; De Cecco L
Gynecol Endocrinol; 1988 Sep; 2(3):205-13. PubMed ID: 3147583
[TBL] [Abstract][Full Text] [Related]
4. Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression.
Hamori M; Zwirner M; Clédon P; Tinneberg HR
Int J Fertil; 1992; 37(3):171-5. PubMed ID: 1355764
[TBL] [Abstract][Full Text] [Related]
5. Induction of ovulation in the patient with polycystic ovarian disease.
Blankstein J; Quigley MM
Endocrinol Metab Clin North Am; 1988 Dec; 17(4):733-49. PubMed ID: 3143566
[TBL] [Abstract][Full Text] [Related]
6. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S
J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563
[TBL] [Abstract][Full Text] [Related]
7. The effects of buserelin on the hormonal states in PCOD.
Willemsen WN; Franssen AM; Rolland R; Vemer HM
Prog Clin Biol Res; 1986; 225():377-89. PubMed ID: 3097673
[No Abstract] [Full Text] [Related]
8. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P
Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730
[TBL] [Abstract][Full Text] [Related]
9. Combined use of gonadotropin-releasing hormone and its analogues for ovulation induction optimization.
Filicori M
Clin Obstet Gynecol; 1993 Sep; 36(3):737-43. PubMed ID: 8403620
[No Abstract] [Full Text] [Related]
10. Ovarian control of pituitary sensitivity of luteinizing hormone secretion to gonadotropin-releasing hormone in women with the polycystic ovary syndrome.
Dafopoulos K; Venetis C; Pournaras S; Kallitsaris A; Messinis IE
Fertil Steril; 2009 Oct; 92(4):1378-1380. PubMed ID: 19467538
[TBL] [Abstract][Full Text] [Related]
11. Hypogonadotropic patients with ultrasonographically detected polycystic ovaries: endocrine response to pulsatile gonadotropin-releasing hormone.
Schachter M; Balen AH; Patel A; Jacobs HS
Gynecol Endocrinol; 1996 Oct; 10(5):327-35. PubMed ID: 8915662
[TBL] [Abstract][Full Text] [Related]
12. [Comparison between purified FSH and hMG for induction of ovulation in women with PCO syndrome].
Uemura T; Yoshimura Y; Ishikawa M; Asukai K; Minaguchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):923-6. PubMed ID: 2507714
[No Abstract] [Full Text] [Related]
13. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary.
Venturoli S; Paradisi R; Fabbri R; Magrini O; Porcu E; Flamigni C
Obstet Gynecol; 1984 Jan; 63(1):6-11. PubMed ID: 6419189
[TBL] [Abstract][Full Text] [Related]
14. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
Nakamura Y; Yamada H; Yoshida K; Manno T; Ubukata Y; Suzuki M; Yoshimura Y
Horm Res; 1990; 33 Suppl 2():43-8. PubMed ID: 2128881
[TBL] [Abstract][Full Text] [Related]
15. Further observations on the therapy of anovulatory infertility with synthetic luteinizing hormone-releasing hormone.
Zarate A; Canales ES; Soria A; Gonzalez A; Schally AV; Kastin AJ
Fertil Steril; 1974 Jan; 25(1):3-10. PubMed ID: 4589422
[No Abstract] [Full Text] [Related]
16. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
[TBL] [Abstract][Full Text] [Related]
17. Ovulation induction with pulsatile luteinizing hormone-releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: endocrine results.
Burger CW; Hompes PG; Korsen TJ; Schoemaker J
Fertil Steril; 1989 Jan; 51(1):20-9. PubMed ID: 2491993
[TBL] [Abstract][Full Text] [Related]
18. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease.
Remorgida V; Venturini PL; Anserini P; Salerno E; de Cecco L
Fertil Steril; 1991 Jan; 55(1):61-5. PubMed ID: 1898892
[TBL] [Abstract][Full Text] [Related]
19. Peripheral steroid-gonadotropin interactions and diagnostic significance of double-stimulation tests with luteinizing hormone-releasing hormone in polycystic ovarian disease.
Moltz L; Römmler A; Schwartz U; Bidlingmaier F; Hammerstein J
Am J Obstet Gynecol; 1979 Aug; 134(7):813-8. PubMed ID: 380343
[No Abstract] [Full Text] [Related]
20. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility.
Felberbaum RE; Reissmann T; Küpker W; Bauer O; al Hasani S; Diedrich C; Diedrich K
Eur J Obstet Gynecol Reprod Biol; 1995 Aug; 61(2):151-5. PubMed ID: 7556837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
